Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 5/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 4/20 | 0.50 |
| ▸ | BAK1 | Q16611 | 4/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.50 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.50 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.50 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL7713405 | 0.98 | BID (0.49) | BIDMCL1BCL2L1BAK1PPARA | |
| Ammonia Solution, Strong SCHEMBL7713404 | 0.98 | BID (0.49) | BIDMCL1BCL2L1BAK1PPARA | |
| SCHEMBL9256709 | 0.95 | BID (0.56) | BIDMCL1BCL2L1BAK1PPARA | |
| SCHEMBL11342368 | 0.94 | BID (0.58) | BIDMCL1BCL2L1BAK1PPARA | |
| SCHEMBL7184885 | 0.94 | BID (0.58) | BIDMCL1BCL2L1BAK1PPARA | |
| SCHEMBL10422649 | 0.94 | BID (0.58) | BIDMCL1BCL2L1BAK1PPARA | |
| SCHEMBL5709971 | 0.94 | BID (0.58) | BIDMCL1BCL2L1BAK1PPARA | |
| SCHEMBL5575883 | 0.94 | BID (0.58) | BIDMCL1BCL2L1BAK1PPARA | |
| SCHEMBL8665018 | 0.94 | BID (0.58) | BIDMCL1BCL2L1BAK1PPARA | |
| Ammonia Solution, Strong SCHEMBL4296360 | 0.93 | BID (0.57) | BIDMCL1BCL2L1BAK1PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399168-B2 | Method for producing toner, two-component developer, developing device and image forming apparatus | SHARP KABUSHIKI KAISHA (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20120316337-A1 | METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP | UNIVERSITE DU MAINE (FR) | 2012-12-13 | — | — | US | disclosed |
| CN-101560272-B | Olefinic polymerization catalyst, preparation method and polymerization method | YINGKOU XIANGYANG CATALYST CO LTD | 2011-04-13 | — | — | CN | disclosed |
| CN-101560273-B | Olefinic polymerization catalyst, preparation method and polymerization method | YINGKOU XIANGYANG CATALYST CO LTD | 2011-03-23 | — | — | CN | disclosed |
| US-20100055597-A1 | METHOD FOR PRODUCING TONER, TWO-COMPONENT DEVELOPER, DEVELOPING DEVICE AND IMAGE FORMING APPARATUS | SHARP KABUSHIKI KAISHA (JP) | 2010-03-04 | — | — | US | disclosed |
| CN-101560273-A | Olefinic polymerization catalyst, preparation method and polymerization method | YINGKOU XIANGYANG CATALYST CO (CN) | 2009-10-21 | — | — | CN | disclosed |
| CN-101560272-A | Olefinic polymerization catalyst, preparation method and polymerization method | YINGKOU XIANGYANG CATALYST CO (CN) | 2009-10-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316337-A1 | METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP | COMT, NAA15, NUDC | BID 2799/4885MCL1 1600/4885BCL2L1 4097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.